gene_2019_scientist_lab_24437.2_rgb
HOLLY SPRINGS, NORTH CAROLINA
Advancing innovation on the East Coast
We're expanding to the East Coast with a 700,000 sq. ft. manufacturing facility in Holly Springs, North Carolina! The site will support our pharma division’s next-generation metabolic medicines portfolio, including treatments for obesity, ultimately helping to deliver life-changing science to patients.

This state-of-the art facility represents a $700+ million investment in the United States with potential expansion in the future, resulting in many new job opportunities! Opportunities are already available and we'll be posting more soon in manufacturing, quality assurance, engineering, construction and more.

Ready to build the future of medicine?  Stay in touch with us by joining our talent community to be notified about future openings as they become available.


img1
Our new facility near Raleigh, North Carolina, an established biopharmaceutical talent hub, will serve as an important new setting within our manufacturing network to help deliver on the promise of our company’s life-changing science and industry-leading pipeline. We are thrilled to establish this relationship with the city of Holly Springs, where we expect to have a positive impact on the local economy and community, as we have across the United States since we pioneered the biotech industry nearly 50 years ago.

Ashley Magargee
Genentech CEO